The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica RFK Jr. & claimed regenerative peptides like BPC 157 The Niche The biggest peptide story of 2026 may not be a new study. It may be the FDA review calendar. BPC 157, TB 500, MOTS c, Semax, and other peptides are headed into FDA advisory review RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion Is BPC 157 Banned? Oral vs. Injectable Forms Explained